bit.bio
bit.bio is seeking a strategic and commercially driven Director of Business Development, Data & Platform Partnerships to lead go-to-market strategy and revenue generation for its Data as a Product and platform assets, focusing on building high-value strategic partnerships in the biotech and AI-enabled drug discovery sectors.
Headquarters
Babraham, England, United Kingdom
Company Size
51-200 employees
Founded
2016
bit.bio is a synthetic biology company that uses its proprietary opti-ox™ technology to precisely, consistently and efficiently reprogram pluripotent stem cells into defined human cell types at scale. They supply off‑the‑shelf and bespoke iPSC‑derived cell products and services to support research, drug discovery, disease modelling and therapeutic development. bit.bio partners with pharma and biotech to accelerate target validation and cell therapy programs by delivering reproducible, well‑characterized human cells. Their platform emphasizes scalability and genetic control to replace variable primary cells and improve preclinical translational relevance.
bit.bio closes a $50 million series C round after its 2025 restructuring
Jan 12, 2026
M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
Jan 9, 2026
bit.bio Raises $50 Million Series C Led by M&G To Scale Human Cell Programming Platform
Jan 10, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for bit.bio.
67% below the average for this role
bit.bio expands on back of lower prices and broader distribution model
3 weeks ago
EVP Head of Global In Silico and AI (all genders)
Evotec
Intern, Computational Oncology
Revolution Medicines
Senior Scientist, Genomics
Genomics
Executive Director, Computational Biology Immunology & Respiratory New Therapeutic Concepts (NTC) Discovery
Digital Biology
Manager, Ecosystem Partnerships & Initiatives
DoorDash
Computational/Bioinformatics
Nykode Therapeutics